| 释义 |
1 ?纤溶酶原激活物抑制物 ...；纤溶酶原激活物抑制物1 [gap=1282]y diseases; deficiency of lung-qi; endothelial cell; tissue polypeptide antigen; pai-1 ... 2 ?尿激酶型纤溶酶原激活物抑制物 ...尿激酶型纤溶酶原激活物抑制物 [gap=2207]Key words：cholestasis-induced liver fibrosis ; Erzhiwan; Shixiaosan; uPA; PAI-1 ... 3 ?抑制剂师 组织蛋白酶A例句翻译_写作句库_爱词霸英语 kinase type PA,uPA)、 组织型PA(tissu type PA,tPA)、Ⅰ型PA抑制剂师(PA inhibitor-1,PAI-1)、2型PA抑制剂(PA inhibitor-2,PAI-2)和uPA受体(uPA receptor, 4 ?抑制物 ...： CNKI:SUN:JFJN.0.2006-06-000 【正文快照】： 目前研究表明,纤溶酶原激活剂抑制物(Plas-minogen activator inhibitor-1,PAI-1)在肝细胞癌(hepatocellcular carcinoma,HCC)的浸润、转移机制中具有重要作..
- 1
Objective To assess the clinical significance of plasma t-PA, PAI-1 in acute cerebral infarction. 目的探讨血浆组织型纤溶酶原激活物(t - PA)及其抑制物(PAI - 1)在急性脑梗死发病中的意义。 - 2
There were significant positive correlations between PAI-1 and WHR, TG, GSP, FINS and UA in the youth and middle-age group. 仅在青中年组与PAI-1表现相关性的指标是腰臀比（WHR）、甘油三酯（TG）、糖化血清蛋白（GSP）、血尿酸（UA）和FINS。 - 3
Objective To investigate the influence of rosiglitazone on blood lipids and plasma PAI-1 activity in type 2 diabetic patients. 目的观察罗格列酮对2型糖尿病患者血脂水平和血浆纤溶酶原激活物抑制剂1 (PAI - 1)活性的影响。
|